{"id":11623,"date":"2024-09-06T07:00:00","date_gmt":"2024-09-06T05:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/"},"modified":"2024-09-06T07:00:00","modified_gmt":"2024-09-06T05:00:00","slug":"irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/","title":{"rendered":"IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success"},"content":{"rendered":"
\n

G\u00f6teborg den 6 september 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) \u2013 ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom \u2013 meddelar i dag att f\u00f6retaget kommer att h\u00e5lla en presentation vid eventet Investing in life science: From seed to success, som h\u00e5lls i Stockholm den 12 september 2024.<\/strong><\/p>\n<\/div>\n

\n

Eventet arrangeras av Biostock och Vator Securities p\u00e5 World Trade Center Stockholm, Klarabergsviadukten 70, i Stockholm. IRLABs vd, Kristina Torfg\u00e5rd, kommer att n\u00e4rvara och presentera bolaget.<\/p>\n

\u201dJag ser fram emot att f\u00e5 presentera IRLABs v\u00e4rldsledande portf\u00f6lj med fem l\u00e4kemedelskandidater inom Parkinsons sjukdom. Samtliga v\u00e5ra projekt \u00e4r \u2019first in class\u2019 och riktade mot olika komplikationer under sjukdomsf\u00f6rloppet, med potential att revolutionera behandlingen av Parkinsons sjukdom i framtiden\u201d, s\u00e4ger Kristina Torfg\u00e5rd, vd f\u00f6r IRLAB.<\/p>\n

Mer information om eventet finns p\u00e5 Biostocks hemsida:
https:\/\/www.biostock.se\/investing-in-life-science\/<\/a><\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Kristina Torfg\u00e5rd, VD
Tel: +46 730 60 70 99
E-post: kristina.torfgard@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar en portf\u00f6lj av transformativa behandlingar f\u00f6r alla stadier av Parkinsons sjukdom. Bolaget har sitt ursprung i Nobelpristagaren Prof. Arvid Carlssons forskargrupp och uppt\u00e4ckten av ett samband mellan st\u00f6rningar i hj\u00e4rnans signalsubstanser och hj\u00e4rnans sjukdomar. Mesdopetam (IRL790), under utveckling f\u00f6r behandling av levodopa-inducerade dyskinesier, har slutf\u00f6rt Fas IIb och \u00e4r i f\u00f6rberedelse f\u00f6r Fas III. Pirepemat (IRL752), befinner sig f\u00f6r n\u00e4rvarande i Fas IIb, och utv\u00e4rderas f\u00f6r sin effekt p\u00e5 balans och fallfrekvens vid Parkinson. IRL757, en substans som utvecklas f\u00f6r behandling av apati vid neurodegenerativa sjukdomar, befinner sig i Fas I. Dessutom utvecklar bolaget de tv\u00e5 prekliniska programmen IRL942 och IRL1117 mot Fas I-studier. IRLAB:s pipeline har genererats av bolagets egenutvecklade systembiologibaserade forskningsplattform Integrative Screening Process (ISP). IRLAB har sitt huvudkontor i Sverige och \u00e4r noterat p\u00e5 Nasdaq Stockholm (IRLAB A). F\u00f6r mer information, bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg den 6 september 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) \u2013 ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom \u2013 meddelar i dag att f\u00f6retaget kommer att h\u00e5lla en presentation vid eventet Investing in life science: From seed to success, som h\u00e5lls i Stockholm den 12 september 2024.<\/p>\n","protected":false},"template":"","class_list":["post-11623","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB deltar p\u00e5 eventet Investing in life science: From seed to success - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg den 6 september 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) \u2013 ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom \u2013 meddelar i dag att f\u00f6retaget kommer att h\u00e5lla en presentation vid eventet Investing in life science: From seed to success, som h\u00e5lls i Stockholm den 12 september 2024.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/\",\"url\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/\",\"name\":\"IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2024-09-06T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success - IRLAB","og_description":"G\u00f6teborg den 6 september 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) \u2013 ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar av Parkinsons sjukdom \u2013 meddelar i dag att f\u00f6retaget kommer att h\u00e5lla en presentation vid eventet Investing in life science: From seed to success, som h\u00e5lls i Stockholm den 12 september 2024.","og_url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/","url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/","name":"IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2024-09-06T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-deltar-pa-eventet-investing-in-life-science-from-seed-to-success\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB deltar p\u00e5 eventet Investing in life science: From seed to success"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/11623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=11623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}